Sepsis Clinical Trial
Official title:
Lactic Acid Levels In Hypotensive Patients Without(Standard) and With Tourniquet
This study seeks to determine whether the Lactic Acid blood level in a critically ill patient
must be drawn with a non-tourniquet venipuncture. The null hypothesis is that there is no
significant difference in Lactic Acid blood level in critically ill patients in a sample
taken from either with a tourniquet or a non-tourniquet veni-puncture.
Monitoring of Lactic acid level is helpful in both identifying potentially serious ill
patients as well as identifying in the ICU patients with high morbidity and mortality.
When a patient arrives to an Emergency Department and that patient is hypotensive (BP less
than or equal to 90 systolic), the nursing staff often starts an IV and if possible draws the
patient's initial blood tests off that first IV site; or if the patient has had an IV started
in the field by EMS, the nursing staff will draw blood from another site using a tourniquet.
This initial work up by the nursing staff takes 15 -20 minutes before a physician may see the
patient. Since the present standard Lactic Acid test must be drawn either by arterial
puncture or venipuncture without a tourniquet, this test is rarely done as part of their (the
RNs) initial blood draws.
This simple impediment of needing to repeat the venipuncture without a tourniquet, especially
in patients who often have venous access difficulty, delays the identification of appropriate
patients for early and aggressive management- particularly those with sepsis.
Our hypothesis is that this requirement for a non-tourniquet blood draw is unnecessary.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
| Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
| Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
| Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
| Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
| Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
| Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
| Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
| Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
| Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
| Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
| Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
| Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
| Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
| Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
| Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
| Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
| Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
| Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
| Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |